Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 9 studies | 26% ± 6% | |
epithelial cell | 7 studies | 34% ± 16% | |
basal cell | 5 studies | 27% ± 9% | |
club cell | 5 studies | 19% ± 4% | |
secretory cell | 4 studies | 25% ± 6% | |
luminal cell of prostate epithelium | 4 studies | 25% ± 7% | |
goblet cell | 4 studies | 18% ± 3% | |
ionocyte | 3 studies | 24% ± 4% | |
respiratory goblet cell | 3 studies | 23% ± 7% | |
squamous epithelial cell | 3 studies | 39% ± 20% | |
pancreatic A cell | 3 studies | 28% ± 3% | |
classical monocyte | 3 studies | 24% ± 5% | |
non-classical monocyte | 3 studies | 25% ± 8% | |
oligodendrocyte | 3 studies | 20% ± 3% | |
type I pneumocyte | 3 studies | 24% ± 7% | |
type II pneumocyte | 3 studies | 27% ± 14% | |
GABAergic neuron | 3 studies | 24% ± 1% | |
glutamatergic neuron | 3 studies | 29% ± 7% | |
pancreatic ductal cell | 3 studies | 39% ± 12% | |
group 3 innate lymphoid cell | 3 studies | 22% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3905.95 | 1445 / 1445 | 100% | 56.19 | 183 / 183 |
intestine | 100% | 4672.10 | 966 / 966 | 100% | 68.40 | 527 / 527 |
prostate | 100% | 3181.26 | 245 / 245 | 100% | 66.36 | 502 / 502 |
stomach | 100% | 3248.78 | 359 / 359 | 100% | 64.02 | 286 / 286 |
breast | 100% | 2497.95 | 459 / 459 | 100% | 78.30 | 1117 / 1118 |
brain | 100% | 3687.69 | 2642 / 2642 | 100% | 56.03 | 704 / 705 |
bladder | 100% | 3688.67 | 21 / 21 | 100% | 71.17 | 503 / 504 |
lung | 100% | 3049.23 | 576 / 578 | 100% | 69.85 | 1155 / 1155 |
ovary | 99% | 1561.90 | 178 / 180 | 100% | 51.69 | 430 / 430 |
thymus | 100% | 2239.88 | 652 / 653 | 99% | 51.06 | 599 / 605 |
kidney | 100% | 2422.82 | 89 / 89 | 99% | 43.33 | 889 / 901 |
pancreas | 100% | 1819.91 | 327 / 328 | 99% | 49.30 | 176 / 178 |
skin | 100% | 3227.73 | 1809 / 1809 | 98% | 49.30 | 464 / 472 |
uterus | 99% | 2062.65 | 168 / 170 | 99% | 46.62 | 455 / 459 |
adrenal gland | 100% | 2998.69 | 258 / 258 | 94% | 33.97 | 216 / 230 |
liver | 96% | 1219.81 | 216 / 226 | 84% | 18.17 | 340 / 406 |
adipose | 100% | 2752.95 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 25.54 | 29 / 29 |
muscle | 100% | 4148.40 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1459.01 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 29.37 | 1 / 1 |
blood vessel | 100% | 2786.17 | 1333 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 2738.93 | 922 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 43.81 | 44 / 45 |
heart | 96% | 3852.97 | 824 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 27.48 | 74 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006644 | Biological process | phospholipid metabolic process |
GO_0006580 | Biological process | ethanolamine metabolic process |
GO_0046475 | Biological process | glycerophospholipid catabolic process |
GO_0070291 | Biological process | N-acylethanolamine metabolic process |
GO_0006629 | Biological process | lipid metabolic process |
GO_0005886 | Cellular component | plasma membrane |
GO_0030659 | Cellular component | cytoplasmic vesicle membrane |
GO_0016020 | Cellular component | membrane |
GO_0008889 | Molecular function | glycerophosphodiester phosphodiesterase activity |
GO_0004622 | Molecular function | lysophospholipase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0047395 | Molecular function | glycerophosphoinositol glycerophosphodiesterase activity |
Gene name | GDE1 |
Protein name | Glycerophosphodiester phosphodiesterase 1 (Glycerophosphoinositol glycerophosphodiesterase GDE1) (EC 3.1.4.44) (Lysophospholipase D GDE1) (EC 3.1.4.-) (Membrane-interacting protein of RGS16) (RGS16-interacting membrane protein) Glycerophosphodiester phosphodiesterase 1 |
Synonyms | MIR16 |
Description | FUNCTION: Hydrolyzes the phosphodiester bond of glycerophosphodiesters such as glycerophosphoinositol (GroPIns) and glycerophosphoethanolamine (GroPEth), to yield a glycerol phosphate and an alcohol (By similarity). Hydrolyzes glycerophospho-N-acylethanolamines to N-acylethanolamines in the brain and participates in bioactive N-acylethanolamine biosynthesis such as anandamide (an endocannabinoid), N-palmitoylethanolamine (an anti-inflammatory), and N-oleoylethanolamine (an anorexic). In addition, has a lysophospholipase D activity by hydrolyzing N-acyl-lysoplasmenylethanolamine (N-acyl-lysoPlsEt) to N-acylethanolamine. However lysophospholipase D activity is lower than glycerophosphodiester phosphodiesterase activity (By similarity). Has little or no activity towards glycerophosphocholine (By similarity). . |
Accessions | ENST00000353258.8 H3BU22 ENST00000564172.1 ENST00000569899.5 ENST00000569773.1 H3BNA5 H3BRL5 Q9NZC3 |